BrukerFRA:BKD -1.42%86 EV-to-FCF is 551.73 as of Jul. 07, 2026, which is 1020% above its 10-year median of 49.27. GuruFocus rates FRA:BKD with a GF Score™ of 86/100 and a GF Value™ of €53.37 (Fairly Valued). The stock has 10 warning signs investors should review. Among 417 Medical Devices & Instruments companies, Bruker ranks worse than 97.12% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bruker's Enterprise Value is €9,597 Mil.
Bruker's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €17 Mil. Therefore, Bruker's EV-to-FCF for today is 551.73.
The historical rank and industry rank for Bruker's EV-to-FCF or its related term are showing as below:
FRA:BKD'
s EV-to-FCF Range Over the Past 10 Years
Min: -866.53 Med: 49.27 Max: 725.27
Current: 499.05
During the past 13 years, the highest EV-to-FCF of Bruker was 725.27. The lowest was -866.53. And the median was 49.27.
FRA:BKD's EV-to-FCF is ranked worse than 97.12% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.16
vs FRA:BKD: 499.05
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-07), Bruker's stock price is €53.96.
Bruker's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.204. Therefore, Bruker's PE Ratio (TTM) for today is At Loss.
Bruker (FRA:BKD) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bruker's share price for today is €53.96.
Bruker's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.204.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Bruker EV-to-FCF Related Terms
Bruker EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Bruker's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Bruker's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bruker EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bruker's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Bruker's EV-to-FCF falls into.
Bruker's current Enterprise Value is €9,597 Mil.
Bruker's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bruker (FRA:BKD) has a EV-to-FCF of 551.73 as of Jul. 07, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bruker and its competitors. This is 1020% above median its historical median of 49.27. According to the industry distribution chart, Bruker ranks #405 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 97.1%.
Is Bruker's EV-to-FCF too high?
Bruker's current EV-to-FCF of 551.73 is 1020% above median its 10-year median of 49.27. The Medical Devices & Instruments industry median EV-to-FCF is 23.16. Bruker's value of 551.73 is 2282.3% above this industry median. Based on the distribution chart, Bruker ranks #405 out of 417 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bruker has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bruker's EV-to-FCF compare to GKOS and BIO?
According to the Medical Devices & Instruments industry distribution chart, Bruker ranks #405 out of 417 companies for EV-to-FCF. This places Bruker in the lower half of its industry. The industry median EV-to-FCF is 23.16. Bruker's value of 551.73 is 2282.3% above this benchmark. While the company's 10-year median is 49.27 vs. the industry median of 23.16, Bruker has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.16, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bruker's current EV-to-FCF of 551.73 is 2282.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bruker and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bruker's current EV-to-FCF is 551.73, which is 1020% above median its own 10-year median of 49.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bruker stock overvalued right now?
Based on GuruFocus' analysis, Bruker (FRA:BKD) is currently considered Fairly Valued. The stock's GF Value™ is €53.37, compared to a current price of €53.96 — trading 1.1% above its estimated fair value. The current EV-to-FCF is 551.73, which is 1020% above median its 10-year median of 49.27 and 2282.3% above the Medical Devices & Instruments industry median of 23.16. Bruker's overall GF Score™ is 86/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Bruker (FRA:BKD), the current EV-to-FCF is 551.73 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bruker (FRA:BKD) Overvalued in 2026?
Based on GuruFocus' analysis, Bruker stock appears to be overvalued.
The current stock price of €53.96 is trading 1.1% above its estimated GF Value™ of €53.37.
GuruFocus considers Bruker to be Fairly Valued.
Key valuation signals for FRA:BKD:
EV-to-FCF: 551.73 (1020% above median its 10-year median of 49.27)
GF Value™: €53.37 vs. price of €53.96 (1.1% above fair value)
Industry Position: 2282.3% above the Medical Devices & Instruments median (#405 of 417)
No single metric tells the full story. See the FRA:BKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
86GF Score
Get the complete analysis for FRA:BKD
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:BKD has been successfully added to your 
